TABLE 2.
Molecule | Other name(s) | Inhibitory action | Binding validation | Activity validation | Interface | Binding affinity (KD) | IC50 | References | Vendor |
---|---|---|---|---|---|---|---|---|---|
TB1G1/TB1G2 | Cysteine‐dense peptide (CDP) | iPPI | Rosetta protein design, mammalian surface display, SPR, Co‐IP, PLA | TEAD luciferase reporter, competitive mammalian surface display | 2 |
TB1G1: 31 ± 2 nM TB1G2: 368 ± 4 pM |
NR | 240 | |
Fragment 1 | iPPI scaffold | Co‐crystal structure | ITC, TEAD luciferase reporter | 2 | ~300 μM | NR | 241 | Chemspace (#CSSB00000239375) | |
Peptide 17 | YAP‐TEAD inhibitor 1 | iPPI | Molecular docking, co‐crystal structure, pull‐down assay | Pull‐down assay | 3 | 15 nM | 25 nM | 242 |
Selleckchem (#S8164) AdooQ (#A15858) APExBIO (#A1149) MedChemExpress (#HY‐P2244) |
Peptide 10 | iPPI | Co‐crystal structure, SPR | Pull‐down assay | 3 | 289.5 nM | 297 nM | 243 | ||
Peptides 9, 10 | iPPI | Co‐crystal structure | TR‐FRET | 3 |
Peptide 9: 25 nM Peptide 10: NR |
Peptide 9: 16 ± 5 nM Peptide 10: 9 ± 2 nM |
244 | ||
TEAD‐binding fragment | MFCD00187673 | iPPI scaffold | NMR | ITC | 3 | 77 nM | NR | 245 |
Chemspace (#CSC000003413) |
Dioxo‐benzoisothiazole Example 22 | iPPI | NMR | TEAD luciferase reporter, AlphaLISA® | 3 | NR | 83 nM | 246 | patented: WO2017064277A1 | |
1,2,3‐Triazole‐4‐carbohydrazide derivatives (hit 2) | iPPI | Molecular docking, TSA | MST, TSA, TEAD luciferase reporter, YAP‐TEAD target gene qPCR | 3 | 650 μM | 6.5 μM | 247 |
MCule (#MCULE‐3696035303) MolPort (# MolPort‐002‐604‐580) |
|
Compound 3.1 |
Pyrazidol, Pirlindol, Pirlindolum |
iPPI | Molecular docking, STD NMR | Co‐IP, TEAD luciferase reporter, pull‐down assay, YAP‐TEAD target gene qPCR | 3 | ~12 μM | 33–44 μM (TEAD isoform‐dependent) | 248 |
Chemspace (#CSC020600808) |
Super‐TDU | iPPI | Molecular modelling | Co‐IP, mutational studies | 2&3 | NR | 57.9 ng/ml | 249 |
Selleckchem (#S8554) MedChemExpress (#HY‐P1727) |
Abbreviations: AlphaLISA, amplified luminescent proximity homogenous assay (linked immunosorbent assay); Co‐IP, co‐immunoprecipitation; iPPI, inhibitor of protein–protein interaction; ITC, isothermal titration calorimetry; MST, microscale thermophoresis; NMR, nuclear magnetic resonance; NR, not reported; PLA, proximity ligation assay; SPR, surface plasmon resonance; STD NMR, saturation transfer difference nuclear magnetic resonance; TR‐FRET, time‐resolved fluorescence resonance energy transfer; TSA, thermal shift assay.